7V91.F VISIOMED GROUP EO 001
- Market cap
- EUR 49.4M
- P/E
- -
- P/B
- 1.65x
- ROE
- 8.3%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Dec 2025.
Is 7V91.F undervalued?
Graham numberThe Graham number of VISIOMED GROUP EO 001 cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
VISIOMED GROUP EO 001 fundamental analysis
No fundamental analysis for VISIOMED GROUP EO 001 yet.
VISIOMED GROUP EO 001 stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About VISIOMED GROUP EO 001
Klea Holding SA, together with its subsidiaries, develops health technologies and services in France, the United Arab Emirates, and Saudi Arabia. It operates digitalized medical centers that provide administrative screenings for residency and work visas, preventive health check-ups, and medical fitness tests under the Smart Salem brand. In addition, the company engages in the production of pharmaceuticals. The company was formerly known as Visiomed Group SA and changed its n…
Full company profileVISIOMED GROUP EO 001 financial statements
VISIOMED GROUP EO 001 annual financial statements (EUR; K = thousand, M = million, B = billion, T = trillion)
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | 7.17M | 14.4M | 13.7M | 17.3M | 22.2M |
| Gross Profit | -715K | 3.20M | 6.30M | 8.25M | 9.79M |
| Operating Income | -3.68M | -3.91M | 952K | 1.95M | 3.68M |
| EBITDA | - | -2.21M | 5.85M | 3.88M | 5.31M |
| Net Income | -4.46M | -5.28M | 902K | 1.41M | 2.28M |
| EPS | -0.03 | -0.02 | 0.00 | 0.00 | 0.01 |
| Balance Sheet | |||||
| Total Assets | 44.1M | 36.1M | 36.6M | 37.8M | 37.3M |
| Total Liabilities | 30.0M | 11.8M | 11.8M | 10.0M | 9.68M |
| Shareholders' Equity | 14.1M | 24.3M | 24.1M | 28.0M | 27.6M |
| Cash & Short-term Investments | 6.57M | 2.36M | 2.97M | 3.31M | 5.25M |
| Cash Flow | |||||
| Operating Cash Flow | -6.50M | -1.74M | 1.11M | 932K | 4.93M |
| Capital Expenditure | 196K | 5.52M | 2.61M | 766K | 1.03M |
| Free Cash Flow | -6.70M | -7.26M | -1.50M | 166K | 3.90M |
| Ratios | |||||
| ROE | -31.7% | -21.7% | 3.7% | 5.0% | 8.3% |
| ROA | -10.1% | -14.6% | 2.5% | 3.7% | 6.1% |
| Net Profit Margin | -62.1% | -36.5% | 6.6% | 8.1% | 10.3% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
VISIOMED GROUP EO 001 dividends
VISIOMED GROUP EO 001 has not paid dividends in the last 9 fiscal years.
Last stock split: 1:40 on Mar 19, 2020.
Who owns VISIOMED GROUP EO 001
- Insiders 0.00%
- Institutions 0.97%
- Public & others 99.03%
- Shares outstanding 306M
- Free float 187M
VISIOMED GROUP EO 001 company profile
- Company name
- VISIOMED GROUP EO 001
- Ticker
- 7V91.F
- ISIN
- FR0013481835
- Exchange
- Frankfurt Exchange
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Employees
- 112
- Fiscal year end
- December
- Address
- 34 Rue Laffitte, Paris, France, 75009
- Phone
- 33 1 80 27 29 90
- Website
- kleaholding.com
About VISIOMED GROUP EO 001
Klea Holding SA, together with its subsidiaries, develops health technologies and services in France, the United Arab Emirates, and Saudi Arabia. It operates digitalized medical centers that provide administrative screenings for residency and work visas, preventive health check-ups, and medical fitness tests under the Smart Salem brand. In addition, the company engages in the production of pharmaceuticals. The company was formerly known as Visiomed Group SA and changed its name to Klea Holding SA in June 2024. Klea Holding SA was founded in 2007 and is headquartered in Paris, France.
VISIOMED GROUP EO 001 management
1- Mr. Raphael SmilaCEO & Director